Hematologic Oncology Glossary
100 terms total — 24 showing — Last updated 15 Sep 2026
extramedullary disease EM
Cancer involvement outside the bone marrow, occurring in organs or tissues not typically involved.
MRD negativity
The absence of detectable disease below conventional morphologic thresholds, indicating deep remission.
multiple myeloma
A cancer of plasma cells that typically involves the bone marrow and is characterized by the production of abnormal prot...
Myeloablative conditioning
High-dose chemotherapy and/or radiation therapy given before stem cell transplantation to eradicate malignant cells and...
myelodysplastic syndrome
A group of clonal hematopoietic disorders characterized by dysplastic changes in bone marrow cells and peripheral blood...
myelofibrosis
A myeloproliferative neoplasm characterized by bone marrow fibrosis, extramedullary hematopoiesis, and progressive bone...
neutropenia
A condition characterized by an abnormally low number of neutrophils in the peripheral blood.
non-Hodgkin lymphoma
A heterogeneous group of lymphoid malignancies that do not contain Reed-Sternberg cells and typically spread in a random...
pancytopenia
A hematologic condition characterized by reduction in all three major blood cell lines: red blood cells, white blood cel...
peripheral smear review
Manual microscopic examination of blood cells to assess morphology, distribution, and identify abnormal findings.
Philadelphia chromosome
A specific chromosomal abnormality found in chronic myeloid leukemia and some acute lymphoblastic leukemia cases.
plasmacytosis
An abnormal increase in plasma cells in the bone marrow or other tissues.
polycythemia vera
A myeloproliferative neoplasm characterized by excessive production of red blood cells, typically associated with JAK2 m...
progression-free survival
Clinical endpoint measuring time from treatment start until disease progression or death, whichever occurs first.
R-CHOP
Standard chemotherapy regimen combining rituximab with CHOP for treating B-cell lymphomas. Cornerstone treatment protoco...
Rai staging
Prognostic staging system for chronic lymphocytic leukemia using risk categories. Standard classification tool.
Reed-Sternberg cell
Diagnostic malignant cell characteristic of classical Hodgkin lymphoma. Essential pathologic feature for diagnosis.
relapsed/refractory disease
Hematologic malignancy that has returned after initial treatment response or failed to respond to standard therapy.
remission
The absence or significant reduction of cancer signs and symptoms, classified as complete or partial based on specific c...
reticulocyte count
A measure of immature red blood cells, indicating bone marrow's red cell production activity.
Richter syndrome
The transformation of chronic lymphocytic leukemia into an aggressive large cell lymphoma.
Richter transformation
The transformation of chronic lymphocytic leukemia into a more aggressive lymphoma, typically diffuse large B-cell lymph...
salvage therapy
Treatment approach for patients with refractory or relapsed disease after failure of standard therapies.
splenomegaly
Enlarged spleen commonly seen in hematologic malignancies. Important clinical finding requiring assessment.
thrombocytopenia
A condition characterized by an abnormally low platelet count in the peripheral blood, typically below 150,000 per micro...